Researchers analyzed data from over 4,000 people with systemic lupus erythematosus (SLE) and 2,500 healthy individuals. They looked at the neutrophil-to-lymphocyte ratio (NLR), which is a way to measure certain types of white blood cells in the blood. The study found that people with lupus had significantly higher NLR levels compared to healthy people across various regions, including Europe, Asia, and the Arab world.
The results showed a link between these blood cell levels and the actual activity of the disease. Specifically, patients with active lupus had higher levels than those with inactive lupus. The study also found a positive correlation between these levels and a standard score used to measure lupus severity. However, no significant difference was found specifically for those with lupus nephritis.
It is important to note that this study shows a link, not a cause. While these blood markers may help doctors track disease activity, they are not a standalone tool for diagnosis. Because this is a large-scale review of existing data, it provides a broad overview of trends rather than a new treatment. Patients should talk to their doctors about how these markers might relate to their specific care plan.